NORMAL BONE-MINERAL DENSITY FOLLOWING CURE OF CUSHINGS-SYNDROME

被引:106
作者
MANNING, PJ [1 ]
EVANS, MC [1 ]
REID, IR [1 ]
机构
[1] UNIV AUCKLAND,SCH MED,DEPT MED,AUCKLAND,NEW ZEALAND
关键词
D O I
10.1111/j.1365-2265.1992.tb01437.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Both endogenous and exogenous glucocorticoid excess are well established as causes of osteoporosis. However, there are few data describing bone mineral density in these subjects following the restoration of normal steroid levels. The present study addresses this issue. DESIGN A cross-sectional assessment of bone mineral density in patients cured of Cushing's syndrome, and comparison of each with four normal subjects matched by age, sex, weight, menopausal status and race, was used. PATIENTS Seventeen adults cured of Cushing's syndrome 8.6 +/- 1.6 years (mean +/- SEM) took part. MEASUREMENTS The bone mineral density of the lumbar spine and proximal femur was measured by dual energy X-ray absorptiometry. RESULTS Bone mineral densities, relative to control, were 100 +/- 16, 98 +/- 14, 97 +/- 19 and 98 +/- 16% (mean +/- SD), in the lumbar spine, femoral neck, Ward's triangle and trochanteric regions, respectively. There was a positive relationship between bone density and time since cure (r = 0.24-0.59, in the four regions). In contrast, bone density was significantly reduced in five subjects with active Cushing's disease when similarly matched (BMD = 87 +/- 4, 83 4, 75 +/- 6 and 82 +/- 6%, in the respective regions; 0.01 < P < 0.05). CONCLUSIONS Bone density is reduced in subjects with Cushing's syndrome but not in those having undergone cure some years previously. This implies that steroid-induced osteoporosis is substantially reversible, though long-term prospective studies will be necessary to establish this definitively.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 18 条
[1]  
AARON JE, 1989, CLIN ORTHOP RELAT R, V243, P297
[2]   SKELETAL METABOLISM AND BODY COMPOSITION IN CUSHINGS-SYNDROME [J].
ALOIA, JF ;
ROGINSKY, M ;
ELLIS, K ;
SHUKLA, K ;
COHN, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 39 (06) :981-985
[3]   HISTOMORPHOMETRIC PROFILE, PATHOPHYSIOLOGY AND REVERSIBILITY OF CORTICOSTEROID-INDUCED OSTEOPOROSIS [J].
BRESSOT, C ;
MEUNIER, PJ ;
CHAPUY, MC ;
LEJEUNE, E ;
EDOUARD, C ;
DARBY, AJ .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1979, 1 (04) :303-311
[4]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137
[5]  
GODSCHALK MF, 1988, J BONE MINER RES, V3, P113
[6]  
LUFKIN EG, 1988, AM J MED, V85, P887
[7]   REVERSIBLE GONADOTROPIN DEFICIENCY IN MALE CUSHINGS-DISEASE [J].
LUTON, JP ;
THIEBLOT, P ;
VALCKE, JC ;
MAHOUDEAU, JA ;
BRICAIRE, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (03) :488-495
[8]   RECOVERY FROM STEROID-INDUCED OSTEOPOROSIS [J].
POCOCK, NA ;
EISMAN, JA ;
DUNSTAN, CR ;
EVANS, RA ;
THOMAS, DH ;
HUQ, NL .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :319-323
[9]   PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS [J].
REID, IR .
CLINICAL ENDOCRINOLOGY, 1989, 30 (01) :83-103
[10]   LOW SERUM OSTEOCALCIN LEVELS IN GLUCOCORTICOID-TREATED ASTHMATICS [J].
REID, IR ;
CHAPMAN, GE ;
FRASER, TRC ;
DAVIES, AD ;
SURUS, AS ;
MEYER, J ;
HUQ, NL ;
IBBERTSON, HK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (02) :379-383